Regenics vs Hers: Compounded GLP-1s vs FDA-Approved Wegovy® Options
Compare Regenics vs Hers quickly to decide between compounded GLP-1 access and FDA-approved brand-name options. Verdict: Regenics is a lower-cost cash-pay entry with compounded semaglutide and tirzepatide starting at $139 and $189 for the first month, whereas Hers emphasizes FDA-approved Wegovy® and a personalized care team but requires an active membership for medication access.
How Regenics vs Hers differ at a glance
This comparison focuses on the clearest differences supported by the sources: medication type and regulatory status, pricing and billing structure, clinical oversight and care model, additional therapies or services, and membership or availability constraints.
| Criteria | Regenics | Hers |
|---|---|---|
| Medication type | Compounded semaglutide & tirzepatide | FDA-approved Wegovy® and other brand-name GLP-1s (not compounded) |
| Starting price | Semaglutide $139 first month; tirzepatide $189 first month | Wegovy® from $149/mo; injectable options from $199/mo |
| Renewal and fees | Promotional pricing applies to the first month only; renewals higher | Active Hers Weight Loss Membership required; membership billed separately |
| Clinical oversight | Licensed nurse practitioners review intake and oversee prescriptions | Personalized care team with ongoing dose check-ins and clinician review |
| Additional offerings | Sermorelin peptide therapy add-on available | Personalized care team and dose check-ins; no compounded alternatives |
| Regulatory note | Compounded medications are not FDA-approved finished products | Offers FDA-approved brand-name medications like Wegovy® and Zepbound® |
Medication type and regulatory status
Regenics provides compounded semaglutide and tirzepatide prepared by U.S. licensed compounding pharmacies. The source explicitly notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Hers offers FDA-approved brand-name Wegovy® and other named GLP-1s and states it does not offer compounded products. This is a primary distinction for people weighing regulatory status.
Explore Hers FDA-approved options
Pricing structure and membership
Price presentation differs sharply. Regenics lists semaglutide starting at $139 first month and tirzepatide at $189 first month, and the source warns promotional pricing applies to the first month only with higher renewal rates. Hers lists Wegovy® from $149/mo and shows membership requirements: an active Hers Weight Loss Membership is required and billed separately, with a first-month membership fee and auto-renewal at a higher monthly rate. The Hers source states medication is not available without an active membership.
Clinical oversight and care model
Both providers require a licensed clinician to determine medical appropriateness. Regenics advertises nurse-practitioner-led GLP-1 care with nurse practitioners reviewing intake before prescribing. Hers emphasizes a personalized care team with ongoing dose check-ins and clinician review. The sources show Regenics centers on nurse-practitioner oversight and a compounding pharmacy network, while Hers emphasizes ongoing dose management and a multidisciplinary team.
Additional therapies and services
Regenics specifically offers Sermorelin peptide therapy as an add-on, described as a 15mg injectable peptide therapy priced at $399 in the captured FAQ. Hers does not offer compounded medications and focuses on brand-name GLP-1 access with dose check-ins. If a secondary peptide option matters, only Regenics lists that offering in the captured evidence.
Regenics vs Hers: final assessment
Regenics is best known from the source as a mid-pack, cash-pay telehealth option with compounded semaglutide and tirzepatide starting at $139 and $189 for the first month, nurse-practitioner oversight, and a Sermorelin add-on. Hers is presented as a brand-name, FDA-approved option offering Wegovy® from $149 but requires an active membership for medication access and emphasizes a personalized care team and ongoing dose check-ins. Choose based on whether you prioritize compounded pricing and a peptide add-on or FDA-approved brand medications and membership-based care.
Choose Regenics if…
- You want cash-pay compounded semaglutide or tirzepatide with promotional first-month pricing and nurse-practitioner oversight.
- You value having a Sermorelin peptide therapy add-on listed in the source.
Choose Hers if…
- You prefer FDA-approved brand-name Wegovy® and ongoing dose check-ins from a personalized care team and accept the membership requirement.
- You want medications that the source describes as not compounded.
Regenics vs Hers: select the option consistent with your preference for compounded first-month pricing and a peptide add-on or for FDA-approved Wegovy® with membership-based ongoing care.